![](/img/cover-not-exists.png)
Pharmacoeconomic Aspects of Different Inhibitors of Tyrosine Kinase in First-Line Therapy of Patients with Advanced Non-Small Cell Lung Cancer with A Mutation in Epidermal Growth Factor Receptor (EGFR) Gene
Ryazhenov, VV, Gorokhova, SG, Gorokhov, VVolume:
19
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.09.2139
Date:
November, 2016
File:
PDF, 71 KB
english, 2016